Page last updated: 2024-08-16

gatifloxacin and clarithromycin

gatifloxacin has been researched along with clarithromycin in 33 studies

Research

Studies (33)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (9.09)	18.2507
2000's	20 (60.61)	29.6817
2010's	9 (27.27)	24.3611
2020's	1 (3.03)	2.80

Authors

Authors	Studies
Keserü, GM	1
Nagashima, R; Nishikawa, T; Tobita, M	1
Appelbaum, PC; Credito, KL; DeWasse, B; Kosowska-Shick, K; McGhee, P; Pankuch, GA	1
Sasaki, T; Takahata, M; Yamazaki, T	1
Fukushima, K; Higashiyama, Y; Hirakata, Y; Kohno, S; Kohno, Y; Miyazaki, Y; Ohno, H; Yanagihara, K	1
Lombardo, F; Obach, RS; Waters, NJ	1
Jia, L; Sun, H	1
Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P	1
Hamasuna, R; Jensen, JS; Osada, Y	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Andrews, JM; Boswell, F; Brenwald, NP; Wise, R	1
Dubois, J; St-Pierre, C	1
Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G	1
Sano, C; Sato, K; Shimizu, T; Tomioka, H	1
Badaró, R; Bumroongkit, C; Corrêa, JC; Dolmann, AL; Juárez Martínez, LG; Mayrinck, LR; Mera, JR; Tamez, R; Yang, JY	1
Muhlestein, JB	1
Aronkyto, T; Chuchalin, AG; Jaaskevi, M; Kahnovskii, I; Kleutgens, K; Lode, H	1
Dick, JD; Hose, S; Hyon, JY; Joo, MJ; O'Brien, TP; Sinha, D	1
Watanabe, K	1
Dean, NC; Hadlock, C; Sperry, P; Suchyta, MS; Wikler, M	1
Haddad, R; Hamam, RN; Khoury, JM; Noureddin, B; Salti, HI	1
Behlau, I; de la Cruz, J; Pineda, R	1
Espandar, L; Meyer, JJ; Moshirfar, M	1
Hibi, T; Iwasaki, E; Masaoka, T; Nakagawa, I; Nishizawa, T; Suzuki, H	1
Chang, CL; Choi, GE; Kang, JE; Kim, JM; Kim, KH; Lee, EY; Tateda, K; Yamaguchi, K	1
Fujita, M; Harada, E; Ikegame, S; Kajiki, A; Matsumoto, T; Miyazaki, M; Nakanishi, Y; Ouchi, H; Tao, Y; Uchino, J; Watanabe, K	1
Borole, AJ; Chilgar, RM; D'Silva, JA; Thomas, M	1
Lin, Y; Miao, M; Shao, Y; Wang, B; Ye, G	1

Reviews

1 review(s) available for gatifloxacin and clarithromycin

Article	Year
Antibiotic treatment of atherosclerosis. Current opinion in lipidology, 2003, Volume: 14, Issue:6 Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Disease; Coronary Restenosis; Diet, Atherogenic; Fluoroquinolones; Gatifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Myocardial Ischemia; Rabbits; Randomized Controlled Trials as Topic; Roxithromycin; Treatment Outcome	2003

Article

Year

Antibiotic treatment of atherosclerosis.

Current opinion in lipidology, 2003, Volume: 14, Issue:6

Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Disease; Coronary Restenosis; Diet, Atherogenic; Fluoroquinolones; Gatifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Myocardial Ischemia; Rabbits; Randomized Controlled Trials as Topic; Roxithromycin; Treatment Outcome

2003

Trials

5 trial(s) available for gatifloxacin and clarithromycin

Article	Year
Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral st Clinical therapeutics, 2003, Volume: 25, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Erythromycin; Female; Fluoroquinolones; Gatifloxacin; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia	2003
A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumonia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	2004
Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Length of Stay; Middle Aged; Pneumonia, Bacterial; Prospective Studies	2006
Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication. Journal of gastroenterology and hepatology, 2008, Volume: 23 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome	2008
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:2 Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Treatment Outcome	2012

Other Studies

27 other study(ies) available for gatifloxacin and clarithromycin

Article	Year
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship	2003
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11 Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated	2005
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2 Topics: Amidohydrolases; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Peptides; Pneumococcal Infections; Species Specificity; Streptococcus pneumoniae; Time Factors	2007
Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae	2007
In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Animals; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Japan; Levofloxacin; Liver; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolines; Spleen	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Support vector machines classification of hERG liabilities based on atom types. Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11 Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve	2008
Comparative antipneumococcal activities of sulopenem and other drugs. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae	2009
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:11 Topics: Microbial Sensitivity Tests; Mycoplasma genitalium; Polymerase Chain Reaction	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteroides fragilis; Chlamydia; Ciprofloxacin; Clarithromycin; Doxycycline; Enterobacter; Erythromycin; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Naphthyridines; Piperazines; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae	1997
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. Diagnostic microbiology and infectious disease, 1999, Volume: 33, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Gatifloxacin; Legionella; Microbial Sensitivity Tests; Rifampin	1999
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5 Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae	1999
Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex. International journal of antimicrobial agents, 2002, Volume: 19, Issue:2 Topics: Anti-Infective Agents; Cell Line; Clarithromycin; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex	2002
Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis. Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:8 Topics: Administration, Topical; Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits	2004
[Evaluation of gatifloxacin-based triple therapy for refractory H. pylori]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2005, Volume: 102, Issue:5 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged	2005
Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone. Ophthalmology, 2006, Volume: 113, Issue:6 Topics: Adult; Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Clarithromycin; Corneal Stroma; Debridement; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Postoperative Complications; Surgical Flaps	2006
Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:7 Topics: Adult; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Surgical Flaps; Surgical Wound Infection	2007
Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:11 Topics: Adult; Amikacin; Anti-Infective Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Quinolines	2007
[Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients]. The Korean journal of laboratory medicine, 2010, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Legionella; Legionellosis; Microbial Sensitivity Tests; Naphthyridines	2010
Periprosthetic atypical mycobacterial infection in breast implants: a new kid on the block! Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2013, Volume: 66, Issue:1 Topics: Acetamides; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Breast Implants; Clarithromycin; Female; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Mammaplasty; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Reoperation	2013
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021. Helicobacter, 2022, Volume: 27, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Fosfomycin; Furazolidone; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ornidazole; Rifampin; Tinidazole	2022